Berenberg Bank reiterated their buy rating on shares of Genus (LON:GNS – Free Report) in a research report report published on Wednesday morning, MarketBeat.com reports. They currently have a GBX 3,350 target price on the stock.
Genus Stock Performance
Shares of LON GNS opened at GBX 2,066 on Wednesday. The stock has a market capitalization of £1.33 billion, a PE ratio of 4.86, a price-to-earnings-growth ratio of 2.87 and a beta of 0.91. The company has a debt-to-equity ratio of 14.02, a quick ratio of 1.08 and a current ratio of 2.22. Genus has a 52 week low of GBX 1,943 and a 52 week high of GBX 3,220. The stock has a 50 day moving average price of GBX 2,241.60 and a 200 day moving average price of GBX 2,384.43.
Genus (LON:GNS – Get Free Report) last announced its quarterly earnings results on Thursday, September 10th. The company reported GBX 110.30 earnings per share (EPS) for the quarter. Genus had a return on equity of 44.90% and a net margin of 43.35%. Analysts predict that Genus will post 70.96 earnings per share for the current fiscal year.
Genus declared that its Board of Directors has approved a stock buyback plan on Thursday, September 10th that authorizes the company to repurchase £60 million in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 3.9% of its stock through open market purchases. Share repurchase plans are usually a sign that the company’s leadership believes its stock is undervalued.
Insider Buying and Selling at Genus
In other Genus news, insider Jorgen Kokke sold 50,236 shares of the business’s stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of GBX 2,151, for a total transaction of £1,080,576.36. Company insiders own 0.78% of the company’s stock.
About Genus
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
Further Reading
- Five stocks we like better than Genus
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
